it would be nice to know if there is something inherently more dangerous about Omniscan, or the situation involves it being the most used agent.Reports have identified the development of NSF following single and multiple administrations of the gadolinium-based contrast agents. The reports have not always identified a specific agent. Omniscan was the most commonly reported agent, when a specific agent was identified, followed by Magnevist and OptiMARK.
And you always have to wonder about the negative effects over time for someone with good kidneys. Although problems showed up first for people with weaker kidneys, it's foolish to think that good kidneys are unaffected.There have been no reports of NSF among patients with normal kidney function or those with mild-to-moderate kidney insufficiency.
Users browsing this forum: No registered users